《大行》摩通倍升大麥娛樂(01060.HK)目標價至1.2元 降貓眼娛樂(01896.HK)評級至「中性」
摩根大通發表報告指,大麥娛樂(01060.HK)和貓眼娛樂(01896.HK)在今年的股票回報率相差懸殊,大麥上漲91%,貓眼下跌10%,而同期MSCI中國指數上漲17%,該行認爲主要是由於大麥的IP商品化和線下活動票務業務的積極發展。
報告指,大麥從類似於貓眼的電影業代表,轉變爲更多元化的IP及線下娛樂活動經營者,導致估值重估,該行預期這將繼續帶動正面的盈利調整及股價上揚。由於大麥的策略重心及營收風險與貓眼不同,預期大麥的表現將持續領先貓眼。維持對大麥「增持」評級,目標價由0.59升至1.2元。對貓眼評級由「增持」降至「中性」,目標價由12元削至6.8元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.